Search

Home > New FDA Approvals > 057 - Adcetris (brentuximab vedotin) plus chemotherapy for the frontline treatment of advanced classical HL; FDA announces steps to facilitate efficient generic drug review
Podcast: New FDA Approvals
Episode:

057 - Adcetris (brentuximab vedotin) plus chemotherapy for the frontline treatment of advanced classical HL; FDA announces steps to facilitate efficient generic drug review
Category: Science & Medicine
Duration: 00:08:03
Publish Date: 2018-01-04 07:00:00
Description:

January 4, 2018

1:12 - FDA approves sBLA for Adcetris (brentuximab vedotin) plus chemotherapy for the frontline treatment of advanced classical HL

http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-newsArticle&ID=2324372

                                                                              2:42 - FDA announces steps to facilitate efficient generic drug review

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm591184.htm

5:16 - Upcoming activities

Lipocine Inc TLANDO (NDA resubmission) FDA panel review of TLANDO for the proposed indication of testosterone replacement therapy in adult males with hypogonadism 01/10/2018

Aradigm Corp Linhaliq (NDA) FDA panel to review Linhaliq for the treatment of non-cystic fibrosis bronchiectasis patients with chronic lung infections 01/11/2018

Nascent Medical info@nascentmc.com nascentmc.com Check out my new podcast on AI in Medicine at aimedicinenews.com
Total Play: 0